Esophageal squamous cell carcinoma (ESCC) is cancer of the flat cells lining the esophagus, and is currently the ninth most frequent cancer in the world. While environmental risk factors, such as alcohol drinking and cigarette smoking, increase chances of ESCC, several genes are believed to be involved in the origin and/or progression of ESCC. The proteins encoded by these genes include p53, DCC, DEC1, DLEC1, RSRC2, p16 and TGF∫ RII. RSRC2 (arginine/serine-rich coiled-coil protein 2) is a 434 amino acid protein that is believed to function as a transcription factor involved in cell proliferation. Expressed ubiquitously and localized to the nucleus, RSRC2 may serve as a tumor suppressor of esophageal cancer. Overexpression of RSRC2 in an ESCC cell line inhibits cell proliferation, while the loss of RSRC2 is associated with tumor progression. This suggests that RSRC2 is a potential target for esophageal cancer therapy. RSRC2 is expressed as two isoforms produced by alternative splicing.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPIFIHCELISA
recommended for detection of RSRC2 of mouse, rat, human and canine origin by WB, IP, IF, IHC(P) and ELISA